Video Experimental Relacionado
Updated: Jan 7, 2026
11:17
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
14.3K
Heparina: Más de 100 años de anticoagulación
1Therapeutic Reference Materials, Medicines and Healthcare Products Regulator Agency, South Mimms, UK. john.hogwood@mhra.gov.uk.
Handbook of experimental pharmacology
|December 30, 2025
Resumen
La heparina, un anticoagulante vital, ha sido crucial durante más de 100 años en el tratamiento de coágulos sanguíneos y la realización de procedimientos médicos. Los avances como la heparina de bajo peso molecular ofrecen beneficios de autoadministración.
Área de la Ciencia:
- Bioquímica
- Farmacología
- Historia de la Medicina
Sus antecedentes:
- La heparina ha sido indispensable en medicina durante más de un siglo.
- Desempeña un papel fundamental en el manejo de estados protrombóticos y procedimientos como la diálisis.
- La heparina fue fundamental en el desarrollo de la circulación extracorpórea para la cirugía cardíaca.
Objetivo del estudio:
- Proporcionar una visión general completa de la heparina.
- Detallar su descubrimiento, estructura y mecanismo de acción.
- Destacar su uso principal en la anticoagulación.
Principales métodos:
- Revisión de la literatura de datos históricos y científicos sobre la heparina.
- Análisis del papel de la heparina en la práctica clínica y los avances médicos.
- Examen de la evolución de la terapia con heparina, incluida la heparina de bajo peso molecular.
Principales resultados:
- El descubrimiento y la estructura de la heparina son fundamentales para sus propiedades anticoagulantes.
- Su mecanismo de acción es clave para sus aplicaciones terapéuticas.
- El uso de la heparina abarca la profilaxis, el tratamiento de eventos tromboembólicos, la diálisis y la cirugía cardíaca.
Conclusiones:
- La heparina sigue siendo la piedra angular de la terapia anticoagulante.
- El desarrollo de la heparina de bajo peso molecular ha mejorado la comodidad del paciente y la autoadministración.
- Este capítulo ofrece un resumen conciso de la extensa historia y utilidad de la heparina.
Videos de Conceptos Relacionados
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
01:29Venous Thrombosis III: Interprofessional Care
257
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
257
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
274
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
274
01:30Venous Thrombosis IV: Nursing Management
176
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
176
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.0K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.0K